Skin therapy letter 2009-01-01

Adapalene 0.1% and benzoyl peroxide 2.5%: a novel combination for treatment of acne vulgaris.

J K L Tan

Index: Skin Therapy Lett. 14(6) , 4-5, (2009)

Full Text: HTML

Abstract

Topical products commonly used to treat acne include retinoids and antimicrobials, due to their effects on different components of pathogenesis. Accordingly, a fixed combination of adapalene 0.1% and benzoyl peroxide (BPO) 2.5% was developed (Epiduo, Galderma) and was approved by the US FDA in December 2008 for the treatment of acne. The superior efficacy of this combination was demonstrated in 2 large randomized controlled trials. This paper reviews the evidence for efficacy and tolerability of the combination of the retinoid adapalene 0.1% and BPO 2.5%, a once-daily gel formulation for the treatment of acne.

Related Compounds

  • Benzoyl peroxide
  • Adapalene

Related Articles:

The development of a new disposable pipette extraction phase based on polyaniline composites for the determination of levels of antidepressants in plasma samples.

2015-06-19

[J. Chromatogr. A. 1399 , 1-7, (2015)]

Fabrication of Self-Cleaning, Reusable Titania Templates for Nanometer and Micrometer Scale Protein Patterning.

2015-06-23

[ACS Nano 9 , 6262-70, (2015)]

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

2010-01-01

[Chem. Res. Toxicol. 23 , 171-83, (2010)]

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

2011-12-01

[J. Sci. Ind. Res. 65(10) , 808, (2006)]

Surface functionalisation of carbon for low cost fabrication of highly stable electrochemical DNA sensors.

2015-09-15

[Biosens. Bioelectron. 71 , 25-9, (2015)]

More Articles...